HT 1923

Roman name

Pneumo 23 #

The composition and the form of

0.5 ml (1 dose) solution for injection polivalentna pneumococcal vaccine contains purified polysaccharides Streptococcus pneumoniae 0,025 mg (each of the 23 serotypes : 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23/F., 33F), as well as phenol, as a preservative, up to 1.25 mg and isotonic buffer solution (sodium chloride 4.15 mg, dwuhosnovny sodium phosphate 0.065 mg, odnoosnovny sodium phosphate 0.023 mg, water for injection and 0.5 ml) to 0.5 ml; in the injection of one dose, in a cardboard box filled one.

Characteristics

Polyvalent pneumococcal vaccine.

Of drugs

Immunostimulating. One creates a strong immunity specific to the various types serologicakim (23) bacteria Streptococcus pneumoniae.

Indications

Prevention of pneumococcal infections etiology in adults and children older than 2 years (especially respiratory secretions), the people who are members of different risk groups; Sickle cell anaemia, the before or after splenektomii.

Pregnancy and lactation

Not recommended vaccination of pregnant women (no data on the impact of vaccination on the development of the foetus).

Contraindications

Its reaction to a previous vaccine, противопневмококкова я vaccinated less than 3 years prior to vaccination.

Side-Effects

Allergic reactions (with the possibility of the phenomenon Artusa); Sometimes reddening, light sensitivity or compaction at the site injections; Rarely is the slight increase in body temperature, vomiting, fatigue, headache and other functional disorders and minor general reaction duration (average) not more than 24 hours; With 2,531,250, the earlier deadline of the possibility of more severe local reactions.

Patient interaction

Simultaneous immunosupressivei therapy reduces the immune response.

Precautions

In connection with the possibility of serious adverse reactions (type phenomenon Artusa) for the vaccination to adhere strictly to protocol and the need for vaccination (as determine the effectiveness of vaccination was only to persons at risk).

Dosing and Administration

P / or to the in / m; In the primary immunization, a single injection. Revaccination is not less than 5 years, with the exception of those from high-risk groups or those with immunosupressivna therapy.

Directory → Immunotropona funds → Vaccines, serums, fagi → HT 1923